1-octacosanol has been researched along with Disease Models, Animal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, YN; Lu, QS; Miao, ST; Xu, T; Zhou, YJ; Zhu, MY | 1 |
| Guo, T; Hu, T; Li, X; Lin, Q; Luo, F; Nie, Y; Shi, L; Wang, L; Xu, W | 1 |
2 other study(ies) available for 1-octacosanol and Disease Models, Animal
| Article | Year |
|---|---|
Oral administration of octacosanol modulates the gut bacteria and protects the intestinal barrier in ulcerative colitis mice.
Topics: Administration, Oral; Animals; Bacteria; Colitis, Ulcerative; Dextran Sulfate; Disease Models, Animal; Fatty Acids, Volatile; Fatty Alcohols; Mice | 2022 |
Octacosanol Attenuates Inflammation in Both RAW264.7 Macrophages and a Mouse Model of Colitis.
Topics: Animals; Colitis; Disease Models, Animal; Fatty Alcohols; Female; Humans; JNK Mitogen-Activated Protein Kinases; Macrophages; Male; Mice; Mice, Inbred ICR; NF-kappa B; Oryza; p38 Mitogen-Activated Protein Kinases; Plant Extracts; Signal Transduction; Transcription Factor AP-1; Tumor Necrosis Factor-alpha | 2017 |